ArticleBiocybernetics and biomedical engineering2023
Detection of various lung diseases including COVID-19 using extreme learning machine algorithm based on the features extracted from a lightweight CNN architecture.
Article in Biocybernetics and biomedical engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic Performance of Artificial Intelligence-Based Methods for Tuberculosis Detection: Systematic Review.Journal of medical Internet research · 2025Pooled it
- Classification of pulmonary diseases from chest radiographs using deep transfer learning.PloS one · 2025Article
- Multi-class deep learning architecture for classifying lung diseases from chest X-Ray and CT images.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Around the world, several lung diseases such as pneumonia, cardiomegaly, and tuberculosis (TB) contribute to severe illness, hospitalization or even death, particularly for elderly and medically vulnerable patients. In the last few decades, several new types of lung-related diseases have taken the lives of millions of people, and COVID-19 has taken almost 6.27 million lives. To fight against lung diseases, timely and correct diagnosis with appropriate treatment is crucial in the current COVID-19 pandemic. In this study, an intelligent recognition system for seven lung diseases has been proposed based on machine learning (ML) techniques to aid the medical experts. Chest X-ray (CXR) images of lung diseases were collected from several publicly available databases. A lightweight convolutional neural network (CNN) has been used to extract characteristic features from the raw pixel values of the CXR images. The best feature subset has been identified using the Pearson Correlation Coefficient (PCC). Finally, the extreme learning machine (ELM) has been used to perform the classification task to assist faster learning and reduced computational complexity. The proposed CNN-PCC-ELM model achieved an accuracy of 96.22% with an Area Under Curve (AUC) of 99.48% for eight class classification. The outcomes from the proposed model demonstrated better performance than the existing state-of-the-art (SOTA) models in the case of COVID-19, pneumonia, and tuberculosis detection in both binary and multiclass classifications. For eight class classification, the proposed model achieved precision, recall and fi-score and ROC are 100%, 99%, 100% and 99.99% respectively for COVID-19 detection demonstrating its robustness. Therefore, the proposed model has overshadowed the existing pioneering models to accurately differentiate COVID-19 from the other lung diseases that can assist the medical physicians in treating the patient effectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.